US HB275 | 2019-2020 | 116th Congress
Status
Spectrum: Strong Partisan Bill (Democrat 36-2)
Status: Introduced on January 8 2019 - 25% progression, died in chamber
Action: 2019-09-25 - Subcommittee Hearings Held.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 8 2019 - 25% progression, died in chamber
Action: 2019-09-25 - Subcommittee Hearings Held.
Text: Latest bill text (Introduced) [PDF]
Summary
Requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
Title
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsors
Sen. Peter Welch [D-VT] | Rep. Francis Rooney [R-FL] | Rep. Mark Pocan [D-WI] | Rep. Rosa DeLauro [D-CT] |
Rep. Kathy Castor [D-FL] | Rep. David Cicilline [D-RI] | Rep. Elijah Cummings [D-MD] | Rep. Janice Schakowsky [D-IL] |
Rep. Betty McCollum [D-MN] | Rep. Daniel Lipinski [D-IL] | Rep. Stephen Lynch [D-MA] | Rep. Brad Sherman [D-CA] |
Rep. Steve Cohen [D-TN] | Rep. Chellie Pingree [D-ME] | Rep. Debbie Wasserman Schultz [D-FL] | Rep. Peter DeFazio [D-OR] |
Rep. Eleanor Norton [D-DC] | Rep. Ro Khanna [D-CA] | Rep. Raul Grijalva [D-AZ] | Rep. Carolyn Maloney [D-NY] |
Rep. Lucille Roybal-Allard [D-CA] | Rep. Matthew Cartwright [D-PA] | Rep. Harley Rouda [D-CA] | Rep. Christopher Pappas [D-NH] |
Rep. Rashida Tlaib [D-MI] | Rep. Salud Carbajal [D-CA] | Rep. Yvette Clarke [D-NY] | Rep. Mike Quigley [D-IL] |
Rep. Angela Craig [D-MN] | Rep. Nanette Barragan [D-CA] | Rep. Elissa Slotkin [D-MI] | Rep. Jeff Van Drew [R-NJ] |
Rep. Alcee Hastings [D-FL] | Rep. Ruben Gallego [D-AZ] | Rep. Lisa Rochester [D-DE] | Rep. Adam Smith [D-WA] |
Rep. Raul Ruiz [D-CA] | Rep. William Keating [D-MA] |
History
Date | Chamber | Action |
---|---|---|
2019-09-25 | House | Subcommittee Hearings Held. |
2019-01-25 | House | Referred to the Subcommittee on Health. |
2019-01-08 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-01-08 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-01-08 | House | Referred to the Subcommittee on Health. |
2019-01-08 | House | Introduced in House |
Same As/Similar To
HB1346 (Related) 2019-12-10 - Subcommittee Hearings Held.
Subjects
Health
Health care costs and insurance
Inflation and prices
Medicare
Prescription drugs
Public contracts and procurement
Health care costs and insurance
Inflation and prices
Medicare
Prescription drugs
Public contracts and procurement
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/275/all-info |
Text | https://www.congress.gov/116/bills/hr275/BILLS-116hr275ih.pdf |